Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel Bard

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Medicinal Chemistry|May 26, 2006
Discovery of proline sulfonamides as potent and selective hepatitis C virus NS5b polymerase inhibitors. Evidence for a new NS5b polymerase binding siteAriamala Gopalsamy, Rajiv Chopra, Kitae Lim, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of HSD-621 as a Potential Agent for the Treatment of Type 2 DiabetesZhao-Kui Wan, Eva Chenail, Huan-Qiu Li, et al.
Bioorganic & Medicinal Chemistry Letters|December 14, 2011
Discovery of potent and selective matrix metalloprotease 12 inhibitors for the potential treatment of chronic obstructive pulmonary disease (COPD)Yuchuan Wu, Jianchang Li, Junjun Wu, et al.
Journal of Medicinal Chemistry|August 14, 2009
Efficacious 11beta-hydroxysteroid dehydrogenase type I inhibitors in the diet-induced obesity mouse modelZhao-Kui Wan, Eva Chenail, Jason Xiang, et al.
Journal of Medicinal Chemistry|August 4, 2009
ATP-competitive inhibitors of the mammalian target of rapamycin: design and synthesis of highly potent and selective pyrazolopyrimidinesArie Zask, Jeroen C Verheijen, Kevin Curran, et al.
Cell Reports. Medicine|June 7, 2021
NOTCH3-targeted antibody drug conjugates regress tumors by inducing apoptosis in receptor cells and through transendocytosis into ligand cellsKenneth G Geles, Yijie Gao, Andreas Giannakou, et al.
The Journal of Biological Chemistry|November 14, 2012
An ultra-specific avian antibody to phosphorylated tau protein reveals a unique mechanism for phosphoepitope recognitionHeather H Shih, Chao Tu, Wei Cao, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Medicinal Chemistry|May 26, 2006
Discovery of proline sulfonamides as potent and selective hepatitis C virus NS5b polymerase inhibitors. Evidence for a new NS5b polymerase binding siteAriamala Gopalsamy, Rajiv Chopra, Kitae Lim, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of HSD-621 as a Potential Agent for the Treatment of Type 2 DiabetesZhao-Kui Wan, Eva Chenail, Huan-Qiu Li, et al.
Bioorganic & Medicinal Chemistry Letters|December 14, 2011
Discovery of potent and selective matrix metalloprotease 12 inhibitors for the potential treatment of chronic obstructive pulmonary disease (COPD)Yuchuan Wu, Jianchang Li, Junjun Wu, et al.
Journal of Medicinal Chemistry|August 14, 2009
Efficacious 11beta-hydroxysteroid dehydrogenase type I inhibitors in the diet-induced obesity mouse modelZhao-Kui Wan, Eva Chenail, Jason Xiang, et al.
Journal of Medicinal Chemistry|August 4, 2009
ATP-competitive inhibitors of the mammalian target of rapamycin: design and synthesis of highly potent and selective pyrazolopyrimidinesArie Zask, Jeroen C Verheijen, Kevin Curran, et al.
Cell Reports. Medicine|June 7, 2021
NOTCH3-targeted antibody drug conjugates regress tumors by inducing apoptosis in receptor cells and through transendocytosis into ligand cellsKenneth G Geles, Yijie Gao, Andreas Giannakou, et al.
The Journal of Biological Chemistry|November 14, 2012
An ultra-specific avian antibody to phosphorylated tau protein reveals a unique mechanism for phosphoepitope recognitionHeather H Shih, Chao Tu, Wei Cao, et al.
Pageof 2